Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

In Vitro and in Vivo Optimization of Phase Sensitive Smart Polymer for Controlled Delivery of Rivastigmine for Treatment of Alzheimer’s Disease

Pharmaceutical Research(2020)10.1007/s11095-020-2757-6Source: DataRank Database

In Vitro and in Vivo Optimization of Phase Sensitive Smart Polymer for Controlled Delivery of Rivastigmine for Treatment of Alzheimer’s Disease is a research paper published in Pharmaceutical Research (2020). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.95)OA: greenTopics (63)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Divya Sharma ORCID,Amrita Banerjee ORCID,Jagdish Singh ORCID,Lindsey Lipp

Live enrichment

PubMed:31942651 PMC:PMC6996875 OpenAlex:https://openalex.org/W3000414370

National Institutes of Health

Grant: R15GM114701

National Institutes of Health

Grant: 1R15GM114701-01

Modification of insulin molecule for controlled delivery at basal level from triblock copolymers

FWCI

0.95

Citation Percentile

0.7%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

greenLicense: Springer TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/6996875

publisherhttp://link.springer.com/content/pdf/10.1007/s11095-020-2757-6.pdf

publisherhttp://link.springer.com/article/10.1007/s11095-020-2757-6/fulltext.html

journalhttps://doi.org/10.1007/s11095-020-2757-6

Fields of Study

Advancements in Transdermal Drug DeliveryAdvanced Drug Delivery SystemsCholinesterase and Neurodegenerative Diseases0301 basic medicine03 medical and health sciences0302 clinical medicineAlzheimer DiseaseCholinesterase InhibitorsDrug CarriersDrug CompoundingDrug LiberationHumansHydrophobic and Hydrophilic InteractionsKineticsPhase TransitionPolylactic Acid-Polyglycolic Acid CopolymerRivastigmineSolventsStimuli Responsive Polymers

MeSH Terms

RivastigminePolylactic Acid-Polyglycolic Acid CopolymerStimuli Responsive PolymersAlzheimer DiseaseCholinesterase InhibitorsDrug CarriersDrug CompoundingHumansKineticsSolventsPhase TransitionHydrophobic and Hydrophilic InteractionsDrug Liberation

Keywords

RivastigminePharmacologyTransdermalSmart polymerIn vivoAcetylcholinesteraseMedicineDonepezilChemistryDementiaInternal medicineDiseasePolymerBiologyOrganic chemistryAlzheimer’s diseaseControlled releasePhase SensitiveSmart PolymersDrug CarriersDrug CompoundingStimuli Responsive PolymersPhase TransitionDrug LiberationKineticsPolylactic Acid-Polyglycolic Acid CopolymerAlzheimer DiseaseSolventsHumansCholinesterase InhibitorsHydrophobic and Hydrophilic Interactions

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being